Results 71 to 80 of about 8,229 (214)

The Human Ovary Exhibits Dynamic Molecular Remodeling in the Decades Post‐Menopause

open access: yesAging Cell, Volume 25, Issue 10, October 2026.
We analyzed the proteomes of healthy ovaries from 28 postmenopausal women (50–75 years old). We quantified 5812 proteins and observed progressive age‐associated shifts. This fundamentally shifts the notion of the postmenopausal ovary as an inert organ and demonstrates continuous molecular remodeling with relevance to tissue signaling and implications ...
Mark A. Watson   +8 more
wiley   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, Volume 20, Issue 9, Page 2280-2295, September 2026.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Is HE4 a useful endometrioma marker? [PDF]

open access: yes, 2014
Purpose of investigation: By the comparison between most used tumor marker trend (cancer antigen 125: CA 125 and human epididymal secretory protein E4: HE4) before and after laparoscopic surgery, the aim of the present study was to assess HE4 usefulness ...
Tommasi L   +4 more
core   +1 more source

The value of serum CA125, HE4 and imaging examinations in detecting the recurrence of postoperative ovarian cancer

open access: yesZhongguo aizheng zazhi, 2015
Background and purpose: Human epididymis protein 4 (HE4) has been suggested to be a novel biomarker of epithelial ovarian cancer (EOC). The present study aimed to evaluate and compare HE4 with the commonly used marker, carbohydrate antigen 125 (CA125 ...
贾素娟, 王治洁, 张美琴
doaj  

Ovarian Cancer Diagnosis and Chemoresistance Prediction Model Based on cfRNA Molecular Signature

open access: yesAdvanced Science, Volume 13, Issue 52, 18 September 2026.
A deep learning model analyzes cfRNA profiles extracted from the blood of OVCA patients. This innovative approach distinguishes OVCA from healthy controls with high accuracy. Crucially, it reliably predicts patient response to chemotherapy (sensitive versus resistant subgroups).
Qinhao Guo   +14 more
wiley   +1 more source

High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer

open access: yesJournal of Ovarian Research, 2012
The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4 and the ROMA algorithm including HE4 and CA125 in ...
Kalapotharakos Grigorios   +4 more
doaj   +1 more source

Combined Biomarker Panel of Presepsin, HE4, and Oxygenation Index for Sepsis Diagnosis and Prognosis in Intensive Care Unit Patients [PDF]

open access: yes
Jinmei Luo,1,* Shu An,2,* Xuanren Liao,2,* Juehui Wu,2 Laisheng Li2 1Department of Medical Intensive Care Unit, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People’s Republic of China; 2Department of
Wu J, Luo J, Liao X, Li L, An S
core  

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells

open access: yes, 2018
Summary Ovarian cancers are known to evade immunosurveillance and to orchestrate a suppressive immune microenvironment. Here we examine the role of human epididymis protein 4 (HE4), an ovarian cancer biomarker, in immune evasion.
J R Ribeiro   +11 more
core   +1 more source

HE4 as a potential tumor-associated marker in lung cancer

open access: yesСибирский онкологический журнал
The aim of the study was to systematize current data on the use of human epididymis protein 4 (HE4) as a tumor-associated marker for lung cancer (LC) diagnosis, prognosis of treatment response, and monitoring of this category of patients.
I. I. Alentov   +6 more
doaj   +1 more source

Serum human epididymis protein 4 level as a predictor of clinical worsening in idiopathic pulmonary arterial hypertension: a pilot study

open access: yesBMC Cardiovascular Disorders, 2020
Background Human epididymis protein 4 (HE4) was proved to be a novel biomarker for left heart failure. The purpose of this exploratory study was to evaluate the role of HE4 in patients with idiopathic pulmonary arterial hypertension (IPAH) who usually ...
Qi Jin   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy